FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225101426> ?p ?o ?g. }

• W4225101426 endingPage "1785" @default.
• W4225101426 startingPage "1776" @default.
• W4225101426 abstract "Abstract The availability of immune checkpoint inhibitors (ICIs) for the management of advanced hepatocellular cancer (HCC) has changed the treatment paradigm. There are emerging questions regarding the efficacy of subsequent anticancer therapies. The primary aim of this retrospective, multicenter study was to examine the types of anticancer treatment received after ICIs and to assess the impact on post‐ICI survival. We established an international consortium of 11 tertiary‐care referral centers located in the USA (n = 249), Europe (n = 74), and Asia (n = 97), and described patterns of care following ICI therapy. The impact of subsequent therapy on overall survival (OS) was estimated using the Kaplan–Meier method and presented with a 95% confidence interval (CI). A total of 420 patients were treated with ICIs for advanced HCC after one line of systemic therapy (n = 371, 88.8%): 31 (8.8%) had died, 152 (36.2%) received best supportive care (BSC) following ICIs, and 163 patients (38.8%) received subsequent anticancer therapy. Tyrosine kinase inhibitors (TKIs, n = 132, 80.9%), in particular sorafenib (n = 49, 30.0%), were the most common post‐ICI therapy followed by external beam radiotherapy (n = 28, 17.2%), further immunotherapy (n = 21, 12.9%), locoregional therapy (n = 23, 14.1%), chemotherapy (n = 9, 5.5%), and surgery (n = 6, 3.6%). Receipt of post‐ICI therapy was associated with longer median OS compared with those who had received BSC (12.1 vs. 3.3 months; hazard ratio [HR]: 0.4 (95% CI: 2.7–5.0). No difference in OS was noted in those patients who received TKI before ICIs compared with those who received ICIs followed by TKI. Conclusion: Post‐ICI therapy is associated with OS in excess of 12 months, suggesting a role for therapeutic sequencing. OS from TKI therapy was similar to that reported in registration studies, suggesting preserved efficacy following ICIs." @default.
• W4225101426 created "2022-04-30" @default.
• W4225101426 creator A5000475484 @default.
• W4225101426 creator A5007167001 @default.
• W4225101426 creator A5010805361 @default.
• W4225101426 creator A5013417150 @default.
• W4225101426 creator A5014448224 @default.
• W4225101426 creator A5017637849 @default.
• W4225101426 creator A5031516587 @default.
• W4225101426 creator A5032900701 @default.
• W4225101426 creator A5039326252 @default.
• W4225101426 creator A5041438383 @default.
• W4225101426 creator A5045113980 @default.
• W4225101426 creator A5046065062 @default.
• W4225101426 creator A5048681236 @default.
• W4225101426 creator A5054555044 @default.
• W4225101426 creator A5057343975 @default.
• W4225101426 creator A5059152609 @default.
• W4225101426 creator A5059373658 @default.
• W4225101426 creator A5063074565 @default.
• W4225101426 creator A5065803904 @default.
• W4225101426 creator A5069854148 @default.
• W4225101426 creator A5073007668 @default.
• W4225101426 creator A5074633027 @default.
• W4225101426 creator A5079546763 @default.
• W4225101426 creator A5080835260 @default.
• W4225101426 creator A5080871683 @default.
• W4225101426 creator A5082032876 @default.
• W4225101426 creator A5085559293 @default.
• W4225101426 creator A5090621600 @default.
• W4225101426 date "2022-04-28" @default.
• W4225101426 modified "2023-10-01" @default.
• W4225101426 title "Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC" @default.
• W4225101426 cites W1971837077 @default.
• W4225101426 cites W1994193851 @default.
• W4225101426 cites W2277004004 @default.
• W4225101426 cites W2373606074 @default.
• W4225101426 cites W2560499218 @default.
• W4225101426 cites W2560566536 @default.
• W4225101426 cites W2582878252 @default.
• W4225101426 cites W2601414401 @default.
• W4225101426 cites W2606367731 @default.
• W4225101426 cites W2611670894 @default.
• W4225101426 cites W2787358630 @default.
• W4225101426 cites W2794419219 @default.
• W4225101426 cites W2799933121 @default.
• W4225101426 cites W2804297071 @default.
• W4225101426 cites W2805592007 @default.
• W4225101426 cites W2809889937 @default.
• W4225101426 cites W2898126801 @default.
• W4225101426 cites W2898929429 @default.
• W4225101426 cites W2908573150 @default.
• W4225101426 cites W2947020554 @default.
• W4225101426 cites W2995953853 @default.
• W4225101426 cites W2998980069 @default.
• W4225101426 cites W3012211502 @default.
• W4225101426 cites W3025022288 @default.
• W4225101426 cites W3041768625 @default.
• W4225101426 cites W3045387409 @default.
• W4225101426 cites W3049075450 @default.
• W4225101426 cites W3138484572 @default.
• W4225101426 cites W3157507169 @default.
• W4225101426 cites W4242614242 @default.
• W4225101426 doi "https://doi.org/10.1002/hep4.1927" @default.
• W4225101426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35481940" @default.
• W4225101426 hasPublicationYear "2022" @default.
• W4225101426 type Work @default.
• W4225101426 citedByCount "4" @default.
• W4225101426 countsByYear W42251014262023 @default.
• W4225101426 crossrefType "journal-article" @default.
• W4225101426 hasAuthorship W4225101426A5000475484 @default.
• W4225101426 hasAuthorship W4225101426A5007167001 @default.
• W4225101426 hasAuthorship W4225101426A5010805361 @default.
• W4225101426 hasAuthorship W4225101426A5013417150 @default.
• W4225101426 hasAuthorship W4225101426A5014448224 @default.
• W4225101426 hasAuthorship W4225101426A5017637849 @default.
• W4225101426 hasAuthorship W4225101426A5031516587 @default.
• W4225101426 hasAuthorship W4225101426A5032900701 @default.
• W4225101426 hasAuthorship W4225101426A5039326252 @default.
• W4225101426 hasAuthorship W4225101426A5041438383 @default.
• W4225101426 hasAuthorship W4225101426A5045113980 @default.
• W4225101426 hasAuthorship W4225101426A5046065062 @default.
• W4225101426 hasAuthorship W4225101426A5048681236 @default.
• W4225101426 hasAuthorship W4225101426A5054555044 @default.
• W4225101426 hasAuthorship W4225101426A5057343975 @default.
• W4225101426 hasAuthorship W4225101426A5059152609 @default.
• W4225101426 hasAuthorship W4225101426A5059373658 @default.
• W4225101426 hasAuthorship W4225101426A5063074565 @default.
• W4225101426 hasAuthorship W4225101426A5065803904 @default.
• W4225101426 hasAuthorship W4225101426A5069854148 @default.
• W4225101426 hasAuthorship W4225101426A5073007668 @default.
• W4225101426 hasAuthorship W4225101426A5074633027 @default.
• W4225101426 hasAuthorship W4225101426A5079546763 @default.
• W4225101426 hasAuthorship W4225101426A5080835260 @default.
• W4225101426 hasAuthorship W4225101426A5080871683 @default.
• W4225101426 hasAuthorship W4225101426A5082032876 @default.
• W4225101426 hasAuthorship W4225101426A5085559293 @default.
• W4225101426 hasAuthorship W4225101426A5090621600 @default.

• next